cart SHOPPING CART Shopping Cart

BELKYRA® (Deoxycholic acid)

BELKYRA® is an FDA and Medsafe approved injectable, non-surgical treatment for moderate to severe submental fullness, more commonly known as double chin. BELKYRA® is a product of Allergan's - the same company that produces the trusted BOTOX® and Juvederm fillers range. It works by permanently removing  adipocytes (fat cells) when injected into the submental fat under the chin. After a series of treatments this will reduce submental fat and increase definition of the jawline. 
BELKYRA®  has been rigorously tested for efficacy and safety during pre-market trials. Approximately 70% of patients who received BELKYRA® reported a significant improvement in submental fat compared to placebo. 

Before and after-210-400

How many treatments will I need and how much does it cost?
You will need an Initial Consultation to determine if you are a good candidate for this treatment and to fully discuss BELKYRA® treatment and it's possible side effects. 
You will need at least two treatments with 
BELKYRA® with most people requiring 3-4 treatments but up to 6 treatments may be required to get the desired result. Treatments are spaced 6-8 weeks apart to allow your body to completely recover before the next treatment is performed.

The first two treatments are $2,700 altogether, and every subsequent treatment is $1,500. 

Is there any downtime?
There is downtime associated with this treatment. Immediately after injection of BELKYRA® there is swelling in the area under the chin. This means that the treatment is working - the fat cells are lysing (bursting) and your body is undergoing an inflammatory reaction to eliminate the burst fat cells. This swelling can be significant and can last several weeks. We advise planning your treatment around important social and work events. We use local anaesthetic to make the treatment more comfortable for you.

Am I a good candidate for treatment with BELKYRA®?
BELKYRA® is indicated for the treatment of moderate to severe submental fullness. If your submental fullness is classified as mild, if the submental fullness is due to large muscles in this area rather than fat, or if you have excess skin laxity in this area you are not a good candidate for this treatment. 
You must be aged 18 years to 65 years to undergo treatment with BELKYRA® and you must not be pregnant. Your suitability for this treatment can be discussed in your Initial Consultation. 

Please see the Submental Fullness Scale here

Are there any side effects?
Side effects include bruising and/or redness, numbness, warmth, discolouration, and pain at the injection sites. We use local anaesthetic to make it more comfortable, and you may wish to take Panadol before your treatments. FaceWorks will fully discuss BELKYRA® with you at your Initial Consultation. 

For more information about BELKYRA® see the official website from Allergan, the makers of BELKYRA®

To discuss if you are a good candidate for treatment with BELKYRA® please book a BELKYRA® Initial Consultation (required even for existing patients) with Dr Teresa Cattin  here.

Important drug information:

BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. Do not use in people allergic to this medicine, with infection at site of injection, pregnancy and lactation. Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/pain/swelling/numbness/redness/tingling/hardness/itching/discolouration/formation of small areas of hardness/warmth and injection site nerve injury. BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to four years.
BELKYRA® and its design are trademarks of Kythera Biopharmaceuticals, Inc., an Allergan affiliate. ™Trademark of Allergan, Inc. Allergan Australia Pty Ltd, 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. © 2018 Allergan. All rights reserved.